LYRA Archived Articles
Lyra Therapeutics: Innovative CRS Treatment Developer Faces Challenges After Clinical Trial Setback
Published on November 30, 2024
Lyra Therapeutics, Inc. (NASDAQ:LYRA): A Promising Biotech Play with Innovative Drug Delivery Solutions
Published on September 24, 2024